Regina Weger, a 20-year veteran of Hanger, Inc., has been promoted to the company’s President of Products & Services. In this role, she will now also oversee Hanger’s Accelerated Care Plus (ACP) therapeutic solutions subsidiary. Weger will continue to report directly to Hanger’s President and CEO, Vinit Asar, and serve on the Senior Leadership Team for Hanger.
Regina Weger Promoted to President, Products & Services, Hanger

Vinit Asar stated, “As we look beyond 2020 and the COVID-19 pandemic, we remain committed to ensuring Hanger is led by the strongest team, organized in a manner that maximizes our full potential. I am pleased to announce an internal promotion and welcome a new healthcare industry veteran to Hanger. Together these appointments demonstrate our commitment to a culture of building leaders, and will ensure our long-term goal of driving sustained growth for the benefit of all stakeholders.”
“Regina is an exceptional, accomplished and recognized leader in the O&P [orthotics and prosthetics] profession,” stated Asar. “In her new role, she will bring a cohesive strategy and operational focus to the Products & Services segment, enhancing and growing external partnerships with a customer-focused and growth approach.”
“After more than 20 years of serving independent O&P businesses at SPS [Southern Prostetic Supply], I’m excited to expand into a new role leading Hanger’s Products and Services segment,” said Regina Weger to OTW. “Collaboration and customer service will continue to be key focus areas at SPS, and I look forward to enabling successful outcomes for an additional customer base of therapists and allied health professionals at Accelerated Care Plus.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.